Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease
Dyslipidemia is a common finding in patients with thyroid disease, explained by the adverse effects of thyroid hormones in almost all steps of lipid metabolism. Not only overt but also subclinical hypo- and hyperthyroidism, through different mechanisms, are associated with lipid alterations, mainly...
Main Authors: | Melpomeni Peppa, Grigoria Betsi, George Dimitriadis |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Journal of Lipids |
Online Access: | http://dx.doi.org/10.1155/2011/575840 |
Similar Items
-
Cardiovascular effects of overt and subclinical hyperthyroidism: focus on differentiated thyroid cancer
by: Thera P Links, et al.
Published: (2021-02-01) -
Evaluation of Dyslipidemia, Lipid Ratios and Atherogenic Index as Cardiovascular Risk Factors in Overt and Subclinical Hypothyroid Patients
by: Shivakrishna G, et al.
Published: (2013-07-01) -
Endothelial dysfunction and the risk of atherosclerosis in overt and subclinical hypothyroidism
by: Aasem Saif, et al.
Published: (2018-10-01) -
Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy
by: Sabitha Palazhy, et al.
Published: (2017-01-01) -
Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism
by: Cheng Han, et al.
Published: (2016-01-01)